Role of the serotonin system in ADHD: treatment implications

References

• Banaschewski T, Coghill DR, Santosh PJ et al. Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guidelines. Eur. Child Adolesc. Psychiatry15, 476–495 (2006).
   PubMed Web of Science ®Google Scholar
• Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev. Neurother.5, 525–539 (2005).
   PubMedGoogle Scholar
• No authors listed. Medication for children with attentional disorders. Committee of Children with Disabilities and Committee on Drugs. Pediatrics98, 301–304 (1996).
   PubMed Web of Science ®Google Scholar
• Jensen PS, Arnold LE. National institute of mental health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics113, 754–761 (2004).
   PubMedGoogle Scholar
• Oades RD. Attention deficit disorder with hyperactivity (ADDH): the contribution of catecholaminergic activity. Prog. Neurobiol.29, 365–391 (1987).
   PubMed Web of Science ®Google Scholar
• Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatry26, 676–686 (1987).
   PubMed Web of Science ®Google Scholar
• Steinbusch HWM. Distribution of serotonin immunoreactivity in the central nervous system of the rat: cell bodies and terminals. Neuroscience6, 557–618 (1981).
   PubMed Web of Science ®Google Scholar
• Eastwood SL, Burnet PW, Gittins W et al. Expression of serotonin 5-HT2Areceptors in the human cerebellum and alterations in schizophrenia. Synapse42, 104–114 (2001).
   PubMedGoogle Scholar
• Sari Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev.28, 565–582 (2004).
   PubMedGoogle Scholar
• Jacobs BL, Fornal CA. Serotonin and behavior: a general hypothesis. In: Psychopharmacology: The Fourth Generation of Progress. Bloom FE, Kupfer DJ (Eds). Raven Press, NY, USA 461–469 (1995).
   Google Scholar
• Karadottir R, Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience145, 1426–1438 (2007).
   PubMed Web of Science ®Google Scholar
• Cote F, Fligny C, Bayard E et al. Maternal serotonin is crucial for murine embryonic development. Proc. Natl Acad. Sci. USA104, 329–334 (2007).
   PubMed Web of Science ®Google Scholar
• Tork I. Anatomy of the serotonergic system. Ann. NY Acad. Sci.600, 9–34 (1990).
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol. Rev.72, 165–229 (1992).
   PubMed Web of Science ®Google Scholar
• Kosofsky BE, Molliver ME. The serotonergic innervation of the cerebral cortex: different classes of axon terminals arise from the dorsal and median raphe nuclei. Synapse1, 153–168 (1987).
   PubMedGoogle Scholar
• Soghomonian J-J, Descarries L, Watkins KC. Serotonin innervation in adult rat neostriatum. II. Ultrastructural features: a radioautographic and immunocytochemical study. Brain Res.481, 67–86 (1989).
   PubMedGoogle Scholar
• Oades RD. The roles of norepinephrine and serotonin in ADHD. In: Attention Deficit Hyperactivity Disorder: From Genes to Animal Models to Patients. Gozal D, Molfese DL (Eds). Humana Press, Tootawa, NY, USA 97–130 (2005).
   Google Scholar
• Coleman M. Serotonin concentrations in whole blood of hyperactive children. J. Pediatr.78, 985–990 (1971).
   PubMed Web of Science ®Google Scholar
• Saul RC, Ashby CD. Measurement of whole blood serotonin as a guide in prescribing psycho-stimulant medication for children with attentional deficits. Clin. Neuropharmacology9, 189–195 (1986).
   PubMedGoogle Scholar
• Ferguson HB, Pappas BA, Trites RL et al. Plasma free and total tryptophan, blood serotonin, and the hyperactivity syndrome: no evidence for the serotonin deficiency hypothesis. Biol. Psychiatry16, 231–238 (1981).
   PubMedGoogle Scholar
• Bhagnan HN, Coleman M, Coursina DB. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phopsphate contents in hyperactive children. Pediatrics55, 437–441 (1975).
   PubMedGoogle Scholar
• Spivak B, Vered Y, Yoran-Hegesh R, Averbuch E, Mester R, Graf E. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatr. Scand.99, 300–304 (1999).
   PubMedGoogle Scholar
• Irwin M, Belendink K, McCloskay K, Freedman DX. Trypotophan metabolism in children with attention deficit disorder. Am. J. Psychiatry138, 1082–1085 (1981).
   PubMed Web of Science ®Google Scholar
• Shetty T, Chase TN. Central monoamines and hyperkinesis of childhood. Neurology26, 1000–1002 (1976).
   PubMedGoogle Scholar
• Castellanos FX, Elia J, Kruesi MJP et al. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res.52, 305–316 (1994).
   PubMedGoogle Scholar
• Rapoport JL, Quinn PO, Scribanic N et al. Platelet serotonin of hyperactive school age boys. Br. J. Psychiatry125, 138–140 (1974).
   PubMedGoogle Scholar
• Kusaga A, Yamashita Y, Koeda T et al. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Ann. Neurol.52, 371–374 (2002).
   Google Scholar
• Oades RD, Müller BW. The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis. Behav. Brain Res.88, 95–102 (1997).
   PubMedGoogle Scholar
• Oades RD, Daniels R, Rascher W. Plasma neuropeptide Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder (ADHD). Psychiatry Res.80, 177–186 (1998).
   PubMedGoogle Scholar
• Oades RD, Roepcke B, Schepker R. A test of conditioned blocking and its development in childhood and adolescence: relationship to personality and monoamine metabolism. Dev. Neuropsychol.12, 207–230 (1996).
   Web of Science ®Google Scholar
• Oades RD. Dopamine may be ‘hyper’ with respect to noradrenaline metabolism, but ‘hypo’ with respect to serotonin metabolism in children with ADHD. Behav. Brain Res.130, 97–101 (2002).
   PubMedGoogle Scholar
• O’Neill MF, Heron-Maxwell CL, Shaw G. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine and MK-801 but not D1 agonist c-APB. Pharmacol. Biochem. Behav.63, 237–244 (1999).
   PubMedGoogle Scholar
• Barr AM, Lehmann-Masten V, Paulus M et al. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology29, 221–228 (2004).
   PubMed Web of Science ®Google Scholar
• Su Y-A, Si T-M, Zhou D-F et al. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT2A/2C receptors. Eur. J. Pharmacol.564, 123–130 (2007).
   PubMed Web of Science ®Google Scholar
• Hughes ZA, Starr KR, Scott CM et al. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B. Psychopharmacology (Berl.)192, 121–133 (2007).
   PubMedGoogle Scholar
• Pollier F, Sarre S, Aguerre S et al. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology22, 64–76 (2000).
   PubMedGoogle Scholar
• Durand M, Berton O, Aguerre S. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonin systems and the corticotropic axis in SHR and WKY rats. Neuropharmacology38, 893–907 (1999).
   PubMed Web of Science ®Google Scholar
• Stocker SD, Muldoon MF, Sved AF. Blunted fenfluarmine-evoked prolactin secretion in hypertensive rats. Hypertension42, 719–724 (2003).
   PubMedGoogle Scholar
• De Villiers AS, Russell VA, Sagvolden T et al.α2-adrenoceptor mediated inhibition of 3Hdopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem. Res.20, 427–433 (1995).
   PubMedGoogle Scholar
• Boix F, Qiao S-W, Kolpus T et al. Chronic MAO-B inhibition does not affect behavior in an animal model of attention deficit disorder. Eur. J. Neurosci.8, 172 (1995).
   Google Scholar
• Hoffmann P, Elam M, Thoren P et al. Effects of long-lasting voluntary running on the cerebral levels of dopamine, serotonin and their metabolites in the spontaneously hypertensive rat. Life Sci.54, 855–861 (1994).
   PubMed Web of Science ®Google Scholar
• Gauffre J-C, Aquerre S, Mormede P et al. Cortical 3Hketanserin binding and 5HT2A receptor-mediated inositol phosphate production in the spontaneously hypertensive rat and Lewis rat strains. Neurosci. Lett.236, 112–116 (1997).
   PubMedGoogle Scholar
• Berton O, Aguerre S, Sarrieau A et al. Differential effects of social stress on central serotonergic activity and emotional reactivity in Lewis and spontaneously hypertensive rats. Neuroscience82, 147–159 (1997).
   Google Scholar
• Dev BR, Philip L. Extracellular catechol and indole turnover in the nucleus of the solitary tract of spontaneously hypertensive and Wistar–Kyoto normotensive rats in response to drug-induced changes in arterial blood pressure. Brain Res. Bull.40, 111–116 (1996).
   PubMedGoogle Scholar
• Tsukamoto K, Sved AF, Ito S et al. Enhanced serotonin-mediated responses in the nucleus tractus solitarius of spontaneously hypertensive rats. Brain Res.863, 1–8 (2000).
   PubMed Web of Science ®Google Scholar
• Russell VA, Lam D, Sagvolden T et al. Monoaminergic aspects of animal models of ADHD. In: Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward. Oades RD (Ed.). Nova Science Publishing Inc., Hauppauge, NY, USA 77–108 (2006).
   Google Scholar
• Mehlman PT, Westergaard GC, Hoos BJ et al. CSF 5-HIAA and night-time activity in free-ranging primates. Neuropsychopharmacology22, 210–218 (2000).
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Elia J, Kruesi MJP et al. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder Neuropsychopharmacology14, 125–137 (1996).
   PubMed Web of Science ®Google Scholar
• Gadow KD. Pediatric psychopharmacology: a review of recent research. J. Child Psychol. Psychiatry33, 153–195 (1992).
   PubMed Web of Science ®Google Scholar
• Malhotra S, Santosh PJ. An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry37, 364–371 (1998).
   PubMedGoogle Scholar
• Clarke AR, Barry RJ, McCarthy R et al. EEG predictors of good response to imipramine hydrochloride in children with attention deficit/hyperactivity disorder. In: Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward. Oades RD (Ed.). Nova Science Publishing Inc., Hauppauge, NY, USA 77–108 (2006).
   Google Scholar
• Leonard BE, McCartan D, White J et al. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum. Psychopharmacol.19, 151–180 (2004).
   PubMed Web of Science ®Google Scholar
• Treisman AM. Strategies and models of selective attention. Psychol. Rev.76, 282–299 (1969).
   PubMed Web of Science ®Google Scholar
• Shiffrin RM, Schneider W. Controlled and automatic human information processing: II. Perceptual learning, automatic attending and a general theory. Psychol. Rev.84, 127–190 (1977).
   Web of Science ®Google Scholar
• Posner MI, Snyder CRR. Facilitation and inhibition in the processing of signals. In: Attention and Performance. Rabbitt PM, Dornic S (Eds). Academic Press, London, NY, USA 669–681 (1975).
   Google Scholar
• Neisser U. Cognitive Psychology. Appleton-Century-Croft, NY, USA (1967).
   Google Scholar
• Posner MI, Petersen SE. The attention system of the human brain. Ann. Rev. Neuroscience13, 25–42 (1990).
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Fornal CA, Wilkinson LO. Neurophysiological and neurochemical studies of brain serotonergic neurons in behaving animals. Ann. NY Acad. Sci.600, 260–271 (1990).
   PubMedGoogle Scholar
• Oades RD. The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neurosci. Biobehav. Rev.9, 261–283 (1985).
   PubMed Web of Science ®Google Scholar
• Posner MI, Rothbart MK, Sheese BE. Attention genes. Dev. Sci.10, 24–29 (2007).
   PubMed Web of Science ®Google Scholar
• Hurley LM, Pollak GD. Serotonin differentially modulates responses to tones and frequency-modulated sweeps in the inferior colliculus. J. Neurosci.19, 8071–8082 (1999).
   PubMed Web of Science ®Google Scholar
• Hegerl U, Juckel G. Auditory evoked dipole source activity: indicator of central serotonergic dysfunction in psychiatric patients? Pharmacopsychiatry27, 75–78 (1994).
   PubMed Web of Science ®Google Scholar
• Pfefferbaum A, Roth WT, Ford JM. Event-related potentials in the study of psychiatric disorders. Arch. Gen. Psychiatry52, 559–564 (1995).
   PubMed Web of Science ®Google Scholar
• Oades RD. Connections between studies of the neurobiology of attention, psychotic processes and event-related potentials. Electroencephalogr. Clin. Neurophysiol.44, 428–438 (1995).
   Google Scholar
• Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol. Psychiatry33, 173–187 (1993).
   PubMed Web of Science ®Google Scholar
• Gallinat J, Senkowski D, Wernicke C et al. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology28, 530–532 (2003).
   PubMedGoogle Scholar
• Curran S, Purcell S, Craig I et al. The serotonin transporter gene as a QTL for ADHD. Am. J. Med. Genet.134, 42–47 (2005).
   Google Scholar
• Li J, Wang Y, Zhou R et al. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am. J. Med. Genet.144B, 14–19 (2007).
   PubMedGoogle Scholar
• Nathan PJ, Segrave R, Phan KL et al. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum. Psychopharmacol.21, 47–52 (2006).
   PubMedGoogle Scholar
• Uhl I, Gorynia I, Gallinat J et al. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum. Psychopharmacol.21, 463–471 (2005).
   Google Scholar
• Nathan PJ, O’Neill B, Croft RJ. Is the loudness dependence of the auditory evoked potential a sensitive and selective in vivo marker of central serotonergic function? Neuropsychopharmacology30, 1584–1585 (2005).
   PubMedGoogle Scholar
• Dierks T, Barta S, Demisch L et al. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology (Berl.)146, 101–107 (2000).
   Google Scholar
• Kähkönen S, Mäkinen V, Jääskeläinen IP et al. Serotonergic modulation of mismatch negativity. Psychiatry Res.138, 61–74 (2005).
   PubMedGoogle Scholar
• Oades RD, Dittmann-Balcar A, Schepker R et al. Auditory event-related potentials and mismatch negativity in healthy children and those with attention-deficit- or Tourette-like symptoms. Biol. Psychol.43, 163–185 (1996).
   PubMed Web of Science ®Google Scholar
• Hegerl U. Event-related potentials and clinical response to serotonin agonists in patients with affective disorders. Eur. Arch. Psychiatry Clin. Neurosci.248(Suppl. 2), 75 (1998).
   Google Scholar
• Satterfield JH, Schell AM, Nicholas T. Preferential processing of attended stimuli in attention-deficit hyperactivity disorder and normal boys. Psychophysiology31, 1–10 (1994).
   PubMed Web of Science ®Google Scholar
• Johnstone SJ, Barry RJ, Anderson JW. Topographic distribution and developmental timecourse of auditory event-related potentials in two subtypes of attention-deficit hyperactivity disorder. Int. J. Psychophysiology42, 73–94 (2001).
   PubMed Web of Science ®Google Scholar
• Sergeant JA, van der Meere JJ. Convergence of approaches in localizing the hyperactivity deficit. In: Advances in Clinical Child Psychology (Volume 13). Lahey BB, Kazdin AE (Eds). Plenum Press, NY, USA 207–245 (1990).
   Google Scholar
• Oades RD. Differential measures of sustained attention in children with attention-deficit/hyperactivity or tic disorders: relationship to monoamine metabolism. Psychiatry Res.93, 165–178 (2000).
   PubMed Web of Science ®Google Scholar
• Nigg JT. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol. Psychiatry57, 1424–1435 (2005).
   PubMed Web of Science ®Google Scholar
• Oades RD, Christiansen H. Cognitive switching processes in young people with attention-deficit/hyperactivity disorder. Arch. Clin. Neuropsychol. (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Jemel B, Achenbach C, Müller B et al. Mismatch negativity results from bilateral asymmetric dipole sources in the frontal and temporal lobes. Brain Topogr.15, 13–27 (2002).
   PubMed Web of Science ®Google Scholar
• Escera C, Corral M-J, Yago E. An electrophysiological and behavioral investigation of involuntary attention towards auditory frequency, duration and intensity changes. Brain Res. Cogn. Brain Res.14, 325–332 (2002).
   PubMedGoogle Scholar
• Smith AB, Taylor EA, Brammer M et al. Neural correlates of switching set as measured in fast, event-related functional magnetic resonance imaging. Hum. Brain Mapp.21, 247–256 (2004).
   PubMedGoogle Scholar
• Smith AB, Taylor EA, Brammer M et al. Task-specific hypoactivation in prefrontal and temporoparietal brain regions during motor inhibition and task switching in medication-naive children and adolescents with attention deficit hyperactivity disorder. Am. J. Psychiatry163, 1044–1051 (2006).
   PubMed Web of Science ®Google Scholar
• Rubia K, Lee F, Cleare AJ et al. Tryptophan depletion reduces right inferior prefrontal activation during no-go trials in fast, event-related fMRI. Psychopharmacology (Berl.)179, 791–803 (2004).
   Google Scholar
• Rubia K, Smith AB, Brammer MJ et al. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am. J. Psychiatry162, 1067–1075 (2005).
   PubMed Web of Science ®Google Scholar
• Loose R, Kaufmann C, Auer DP et al. Human prefrontal and sensory cortical activity during divided attention tasks. Hum. Brain Mapp.18, 249–259 (2003).
   PubMed Web of Science ®Google Scholar
• Häger F, Volz H-P, Gaser C et al. Challenging the anterior attentional system with a continuous performance task: a functional magenetic resonance imaging approach. Eur. Arch. Psychiatry Clin. Neurosci.248, 161–170 (1998).
   PubMed Web of Science ®Google Scholar
• Wiersema JR, van der Meere JJ, Roeyers H. ERP correlates of impaired error monitoring in children with ADHD. J. Neural Transm.112, 1417–1430 (2005).
   PubMed Web of Science ®Google Scholar
• Liotti M, Pliszka SR, Perez R et al. Abnormal brain activity related to performance monitoring and error detection in children with ADHD. Cortex41, 377–388 (2005).
   PubMed Web of Science ®Google Scholar
• Burgio-Murphy A, Klorman R, Shaywitz SE et al. Error-related event-related potentials in children with attention-deficit hyperactivity disorder, oppositional defiant disorder, reading disorder, and math disorder. Biol. Psychol.75, 75–86 (2007).
   PubMed Web of Science ®Google Scholar
• Hajcak G, Simons RF. Error-related brain activity in obsessive–compulsive undergraduates. Psychiatry Res.110, 63–72 (2002).
   PubMed Web of Science ®Google Scholar
• Pailing PE, Segalowitz SJ, Dywan J et al. Error negativity and response control. Psychophysiology39, 198–206 (2002).
   PubMed Web of Science ®Google Scholar
• Sheehan K, Lowe N, Kirley A et al. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol. Psychiatry10, 944–949 (2005).
   PubMed Web of Science ®Google Scholar
• Walitza S, Renner TJ, Dempfle A et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol. Psychiatry10, 1126–1132 (2005).
   PubMed Web of Science ®Google Scholar
• Brookes K-J, Xu X, Chen W et al. Analysis of 51 candidate genes in DSM-IV combined subtype attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatry11, 934–953 (2006).
   PubMed Web of Science ®Google Scholar
• Parsey RV, Oquendo MA, Simpson NR et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using C-11WAY-100635. Brain Res.954, 173–182 (2002).
   PubMed Web of Science ®Google Scholar
• Carver CS, Miller CJ. Relations of serotonin function to personality: current views and a key methodological issue. Psychiatry Res.144, 1–15 (2005).
   Google Scholar
• Coccaro EF, Kavoussi RJ, Sheline YI et al. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology16, 211–216 (1997).
   PubMed Web of Science ®Google Scholar
• Tseng MH, Henderson A, Chow SMK et al. Relationship between motor proficiency, attention, impulse, and activity in children with ADHD. Dev. Med. Child Neurol.46, 381–388 (2004).
   PubMed Web of Science ®Google Scholar
• Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology18, 485–503 (2004).
   PubMed Web of Science ®Google Scholar
• Winstanley CA, Eagle DM, Robbins TW. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev.26, 379–395 (2006).
   PubMed Web of Science ®Google Scholar
• Daruna JH, Barnes PA. A neurodevelopmental view of impulsivity. In: The Impulsive Client: Theory Research And Treatment. McCown WG, Johnson JL, Shure MB (Eds). The American Psychological Association, WA, USA 23–44 (1993).
   Google Scholar
• Evenden JL. Varieties of impulsivity. Psychopharmacology (Berl.)146, 348–361 (1999).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Asherson P. IMAGE Consortium. The molecular genetics of attention deficit hyperactivity disorder: a view from the IMAGE project. Psychiatric Times22(9), 21–23 (2005).
   Google Scholar
• Clarke RA, Murphy DL, Constantino JN. Serotonin and externalizing behavior in young children. Psychiatry Res.86, 29–40 (1999).
   PubMedGoogle Scholar
• Knott P, Haroutunian V, Beirer L et al. Correlations postmortem between ventricular CSF and cortical tissue concentrationsof MHPG, 5-HIAA and HVA in Alzheimer’s disease. Biol. Psychiatry25, 112 (1989).
   Google Scholar
• Stanley M, Träskman-Bendz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci.37, 1279–1286 (1985).
   PubMedGoogle Scholar
• Overtoom CCE, Verbaten MN, Kemner C et al. Effects of methylphenidate, desipramine and l-DOPA on attention and inibition in children with attention deficit hyperactivity disorder. Behav. Brain Res.145, 7–15 (2003).
   PubMed Web of Science ®Google Scholar
• Oades RD, Slusarek M, Velling S et al. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity. World J. Biol. Psychiatry3, 96–100 (2002).
   PubMedGoogle Scholar
• Cheetham SC, Viggers JA, Slater NA et al. 3Hparoxetine binding in rat frontal cortex strongly correlates with 3H5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology32, 737–743 (1993).
   PubMedGoogle Scholar
• Bekker EM, Overtoom CCE, Kooij JJS et al. Disentangling deficits in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry62, 1129–1136 (2005).
   PubMed Web of Science ®Google Scholar
• Birmaher B, Stanley M, Greenhill L et al. Platelet imipramine binding in children and adolescents with impulsive behavior. J. Am. Acad. Child Adolesc. Psychiatry29, 914–918 (1990).
   PubMed Web of Science ®Google Scholar
• Stadler C, Schmeck K, Nowraty I et al. Platelet 5-HT uptake in boys with conduct disorder. Neuropsychobiology50, 244–251 (2004).
   PubMedGoogle Scholar
• van Goozen SHM, Matthys W, Cohen-Kettenis PT et al. Plasma monoamine metabolites and aggression: two studies of normal and oppositional defiant disorder children. Eur. Neuropsychopharmacol.9, 141–147 (2003).
   Google Scholar
• Rubia K, Taylor EA, Smith AB et al. Neuropsychological analyses of impulsiveness in childhood hyperactivity. Br. J. Psychiatry179, 138–143 (2001).
   PubMed Web of Science ®Google Scholar
• Talbot PS. Functional neuroimaging of rapid tryptophan depletion. Psychopharmacology (Berl.)20, A2–A7 (2006).
   Google Scholar
• Cahir MC. Effect of acute and chronic tryptophan depletion on serotonergic metabolism and receptors in the rat brain. Psychopharmacology (Berl.)20, A2–A5 (2006).
   Google Scholar
• Dalley JW, Theobald DE, Eagle DM et al. Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology26, 716–728 (2002).
   PubMed Web of Science ®Google Scholar
• Winstanley CA, Dalley JW, Theobald DEH et al. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology29, 1331–1343 (2004).
   PubMed Web of Science ®Google Scholar
• Clarke HF, Walker SC, Dalley JW et al. Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb. Cortex17, 18–27 (2005).
   Google Scholar
• Antrop I, Stock P, Verte S et al. ADHD and delay aversion: the influence of non-temporal stimulation on choice for delayed rewards. J. Child Psychol. Psychiatry47, 1152–1158 (2006).
   PubMed Web of Science ®Google Scholar
• Winstanley CA, Dalley JW, Theobald DE et al. Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl.)170, 320–331 (2003).
   PubMedGoogle Scholar
• Winstanley CA, Theobald DEH, Dalley JW et al. Interactions between serotonin and dopamine in the control of impulsive choice inrRats: therapeutic implications for impulse control disorders. Neuropsychopharmacology30, 669–682 (2005).
   PubMed Web of Science ®Google Scholar
• Winstanley CA, Theobald DEH, Dalley JW et al. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb. Cortex16, 106–114 (2006).
   PubMed Web of Science ®Google Scholar
• Kalenscher T, Ohmann T, Güntürkün O. The neuroscience of impulsive and self-controlled decisions. Int. J. Psychophysiology62, 203–211 (2006).
   PubMed Web of Science ®Google Scholar
• Higley JD, Thompson WW, Champoux M et al. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in Rhesus monkeys (Macaca mulatta). Arch. Gen. Psychiatry50, 615–623 (1993).
   PubMed Web of Science ®Google Scholar
• Virkkunen M, Goldman D, Nielsen DA et al. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J. Psychiatry Neurosci.20, 271–275 (1995).
   PubMed Web of Science ®Google Scholar
• Comings DE, Gade-Andavolu R, Gonzalez N et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin. Genet.58, 31–40 (2000).
   PubMed Web of Science ®Google Scholar
• Evenden JL, Ryan CN. The pharmacology of impulsive behavior in rats. VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl.)146, 413–421 (1999).
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Zhu R et al. Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am. J. Med. Genet.132B, 59–63 (2005).
   PubMedGoogle Scholar
• Sandou F, Amara DA, Dierich A et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science265, 1875–1878 (1994).
   PubMedGoogle Scholar
• Dulawa SC, Hen R, Scearce-Levie K et al. Serotonin1B receptor modulation of startle reactivity, habituation and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology (Berl.)132, 125–134 (1997).
   PubMed Web of Science ®Google Scholar
• Barot SK, Ferguson SM, Neumaier JF. 5-HT1B receptors in nucleus accumbens efferents enhance both rewarding and aversive effects of cocaine. Eur. J. Neurosci.25, 3125–3131 (2007).
   PubMedGoogle Scholar
• Hawi Z, Dring M, Kirley A et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample. Mol. Psychiatry7, 718–725 (2002).
   PubMed Web of Science ®Google Scholar
• Quist JF, Barr CL, Schachar RJ et al. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol. Psychiatry8, 98–102 (2003).
   PubMed Web of Science ®Google Scholar
• Ogdie MN, Fisher SE, Yang M et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13 and 17p11. Am. J. Hum. Genet.75, 661–668 (2004).
   PubMedGoogle Scholar
• Smoller JW, Biederman J, Arbeitman L et al. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol. Psychiatry59, 460–469 (2006).
   PubMedGoogle Scholar
• Bobb AJ, Addington AM, Sidransky E et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet.134B, 67–72 (2005).
   PubMedGoogle Scholar
• Heiser P, Dempfle A, Friedel S et al. Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample. J. Neural Transm.114, 513–521 (2007).
   PubMedGoogle Scholar
• Ickowicz A, Feng Y, Wigg K et al. The serotonin receptor HTR1B: gene polymorphisms in attention deficit hyperactivity disorder. Am. J. Hum. Genet.144B, 121–124 (2007).
   Google Scholar
• Barone P, Jordan D, Atger F et al. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by 3H5-HT, in frontal cortex and the hippocampal region of the human brain. Brain Res.638, 85–94 (1994).
   PubMedGoogle Scholar
• Quist JF, Barr CL, Schachar RJ et al. Evidence for the serotonin 5-HTR2A gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol. Psychiatry5, 537–541 (2000).
   PubMedGoogle Scholar
• Galili-Weisstub E, Segman RH. Attention deficit and hyperactivity disorder: review of genetic association studies. Isr. J. Psychiatry Relat. Sci.40, 57–66 (2003).
   PubMed Web of Science ®Google Scholar
• Guimara APM, Zeni C, Polanczyk GV et al. Serotonin genes and attention deficit/ hyperactivity disorder in a Brazilian sample: preferential transmission of the HTR2A 452His allele to affected boys. Am. J. Med. Genet.144B, 69–73 (2007).
   PubMedGoogle Scholar
• Su L, Cheng D, Gao X. Association of the 5-HT2A receptor polymorphism and attention deficit hyperactivity disorder (ADHD). Proceedings of the 16th World Congress of IACAPAP. Berlin, Germany, 22–26 August 2004.
   Google Scholar
• Reuter M, Kirsch P, Hennig J. Inferring candidate genes for attention deficit hyperactivity disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS). J. Neural Transm.113, 929–938 (2007).
   Google Scholar
• Li J, Knag C, Wang Y et al. Contribution of 5-HT2A receptor gene -1438A>G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents. Am. J. Med. Genet.141B, 473–476 (2006).
   PubMedGoogle Scholar
• Li J, Wang Y, Zhou R et al. Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects. Neurosci. Lett.407, 107–111 (2006).
   PubMedGoogle Scholar
• Alex KD, Yavanian GJ, McFarlane HG et al. Modulation of dopamine release by striatal 5-HT2C receptors. Synapse55, 242–251 (2005).
   PubMed Web of Science ®Google Scholar
• Bubar MJ, Cunningham KA. Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience146, 286–297 (2007).
   PubMed Web of Science ®Google Scholar
• Stiedl O, Misane I, Koch M et al. Activation of the brain 5-HT2C receptors causes hypo-locomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology52, 949–957 (2007).
   PubMedGoogle Scholar
• Li J, Wang Y, Zhou R et al. Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci. Lett.401, 6–9 (2006).
   PubMedGoogle Scholar
• Lucas G, Compan V, Charnay Y et al. Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biol. Psychiatry57, 918–925 (2005).
   PubMedGoogle Scholar
• Micale V, Leggio GM, Mazzola C et al. Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res.1121, 207–215 (2006).
   PubMedGoogle Scholar
• Varnäs K, Halldin C, Pike VW et al. Distribution of 5-HT4 receptors in the postmortem human brain – an autoradiographic study using 125ISB 207710. Eur. Neuropsychopharmacology13, 228–234 (2003).
   PubMed Web of Science ®Google Scholar
• Paolucci E, Berretta N, Tozzi A et al. Depression of mGluR-mediated IPSCs by 5-HT in dopamine neurons of the rat substantia nigra pars compacta. Eur. J. Neurosci.13, 2743–2750 (2003).
   Google Scholar
• Li J, Wang Y, Zhou R et al. No association of attention-deficit/hyperactivity disorder with genes of the serotonergic pathway in Han Chinese subjects. Neurosci. Lett.403, 172–175 (2006).
   PubMedGoogle Scholar
• Sheehan K, Hawi Z, Gill M et al. No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci. Lett.412, 105–107 (2007).
   PubMedGoogle Scholar
• Reuter M, Ott U, Vaitl D et al. Impaired executive control associated with a variation in the tryptophan hydroxylase-2 gene. J. Cogn. Neurosci.19, 401–408 (2007).
   PubMed Web of Science ®Google Scholar
• Canli T, Omura K, Haas BW et al. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc. Natl Acad. Sci. USA102, 12224–12229 (2005).
   PubMed Web of Science ®Google Scholar
• Manor I, Eisenberg J, Tyano S et al. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am. J. Med. Genet.105, 91–95 (2001).
   PubMed Web of Science ®Google Scholar
• Zoroglu SS, Erdal ME, Alasehirli B et al. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology41, 176–181 (2002).
   Google Scholar
• Kent L, Doerry U, Hardy E et al. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol. Psychiatry7, 908–912 (2002).
   PubMed Web of Science ®Google Scholar
• Langley K, Payton A, Hamshere ML et al. No evidence of association of two 5-HT transporter gene polymorphisms and attention deficit hyperactivity disorder. Psychiatr. Genet.13, 107–110 (2003).
   PubMedGoogle Scholar
• Seeger G, Schloss P, Schmidt MH. Marker gene polymorphisms in hyperkinetic disorder – predictors of clinical response to treatment with methylphenidate? Neurosci. Lett.313, 45–48 (2001).
   PubMedGoogle Scholar
• Seeger G, Schloss P, Schmidt MH et al. Gene–environment interaction in hyperkinetic conduct disorder (HD + CD) as indicated by season of birth variations in dopamine receptor (DRD4) gene polymorphism. Neurosci. Lett.366, 282–286 (2004).
   PubMedGoogle Scholar
• Wigg KG, Takhar A, Ickowicz A et al. Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms. Am. J. Med. Genet.141B, 566–570 (2006).
   PubMedGoogle Scholar
• Schalling D, Asberg M, Edman G et al. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr. Scand.76, 172–182 (1987).
   PubMed Web of Science ®Google Scholar
• Meyer-Lindenberg AS, Buckholtz JW, Kolachana B et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl Acad. Sci. USA103, 6269–6274 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang S, Xin R, Lin S et al. Linkage studies between attention-deficit/hyperactivity disorder and the monoamine oxidase genes. Am. J. Med. Genet.105, 783–788 (2001).
   PubMed Web of Science ®Google Scholar
• Domschke K, Sheehan K, Lowe N et al. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am. J. Med. Genet.134B, 110–114 (2005).
   PubMedGoogle Scholar
• Das M, Bhowmik AD, Sinha S et al. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children. Am. J. Med. Genet.141B, 637–642 (2006).
   PubMedGoogle Scholar
• Lawson DC, Turie D, Langley K et al. Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am. J. Med. Genet.116B, 84–89 (2003).
   PubMed Web of Science ®Google Scholar
• Lung F-W, Yang P, Cheng T-S et al. No allele variation of the MAOA gene promoter in male chinese subjects with attention deficit hyperactivity disorder. Neuropsychobiology54, 147–151 (2006).
   PubMedGoogle Scholar
• Thapar A, Langley K, Asherson P et al. Gene–environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective. Br. J. Psychiatry190, 1–3 (2007).
   PubMed Web of Science ®Google Scholar
• Xu X, Brookes K-J, Chen C-K et al. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry7, 10 (2007).
   PubMedGoogle Scholar
• Manor I, Tyano S, Mel E et al. Family based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol. Psychiatry7, 626–632 (2002).
   PubMed Web of Science ®Google Scholar
• Gade R, Muleman D, Blake H et al. Correlation of length of VNTR alleles at the X-linked MAO-A gene and phenotypic effect in Tourette syndrome and drug abuse. Mol. Psychiatry3, 50–60 (1998).
   PubMed Web of Science ®Google Scholar
• Caspi A, McClay J, Moffitt TE et al. Role of genotype in the cycle of violence in maltreated children. Science297, 851–855 (2002).
   PubMed Web of Science ®Google Scholar
• Manuck SB, Flory JD, Ferrell RE et al. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res.95, 9–23 (2000).
   PubMed Web of Science ®Google Scholar
• Passamonti L, Fera F, Magariello A et al. Monoamine oxidase-A genetic variations influence brain activity associated with inhibitory control: new-insight into the neural correlates of impulsivity. Biol. Psychiatry59, 334–340 (2006).
   PubMed Web of Science ®Google Scholar
• Oades RD. Function and dysfunction of monoamine interactions in children and adolescents with AD/HD. In: Neurotransmitter Interactions and Cognitive Function. Levin ED (Ed.). Birkhauser Verlag, Basel, Switzerland 207–244 (2006).
   Google Scholar
• Bonnin A, Torii M, Wang L et al. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat. Neurosci.10, 588–597 (2007).
   PubMed Web of Science ®Google Scholar
• Ichise M, Vines DC, Gura T et al. Effects of early life stress on 11CDASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared Rhesus monkeys. J. Neurosci.26, 4638–4643 (2006).
   PubMed Web of Science ®Google Scholar
• Slotkin TA, Ryde IT, Tate CA et al. Lasting effects of nicotine treatment and withdrawal on serotonergic systems and cell signaling in rat brain regions: separate or sequential exposure during fetal development and adulthood. Brain Res. Bull.73, 259–272 (2007).
   PubMedGoogle Scholar
• Macri S, Spinelli S, Adriani W et al. Early adversity and alcohol availability persistently modify serotonin and hypothalamic–pituitary–adrenal axis metabolism and related behavior: what experimental research on rodents and primates can tell us. Neurosci. Biobehav. Rev.31, 172–180 (2007).
   PubMedGoogle Scholar
• Schmitz M, Denardin D, Laufer Silva T et al. Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case–control study. J. Am. Acad. Child Adolesc. Psychiatry45, 1338–1345 (2006).
   PubMed Web of Science ®Google Scholar
• Elgen I, Bruaroy S, Laegreid LM. Lack of recognition and complexity of foetal alcohol neuroimpairments. Acta Paediatr.96, 237–241 (2006).
   Google Scholar
• Russell VA, Oades RD, Tannock R et al. Response variability in attention-deficit/ hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav. Brain Funct.2, 30 (2006).
   PubMedGoogle Scholar
• Uehara T, Sumiyoshi T, Matsuoka T et al. Role of 5-HT1A receptors in the modulation of stress-induced lactate metabolism in the medial prefrontal cortex and basolateral amygdala. Psychopharmacology (Berl.)186, 218–225 (2006).
   PubMed Web of Science ®Google Scholar
• Hirst WD, Cheung NY, Rattray M et al. Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase. Brain Res. Mol. Brain Res.61, 90–99 (1998).
   PubMedGoogle Scholar
• Magistretti PJ, Sorg O, Yu N et al. Neurotransmitters regulate energy metabolism in astrocytes: implications for the metabolic trafficking between neural cells. Dev. Neurosci.15, 306–312 (1993).
   PubMedGoogle Scholar
• Whitaker-Azmitia PM, Azmitia EC. Astroglial 5-HT1Areceptors and S-100β in development and plasticity. Perspect. Dev. Neurobiol.2, 233–238 (1994).
   PubMedGoogle Scholar
• Steiner J, Bernstein H-G, Bielau H et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci.8, 2 (2007).
   PubMed Web of Science ®Google Scholar
• Druse MJ, Gillespie RA, Tajuddin NF et al. S100B-mediated protection against the pro-apoptotic effects of ethanol on fetal rhombencephalic neurons. Brain Res.1150, 46–54 (2007).
   PubMedGoogle Scholar
• Gobert A, Rivet J-M, Audinot V et al. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroceptor-mediated control of release. Neuroscience84, 413–429 (1998).
   PubMed Web of Science ®Google Scholar